JAKARTA, Nov 13 (Reuters): China's Silk Road Fund (SRF) and Indonesia's INA sovereign fund INA invest in two state-owned Indonesian pharmaceuticals companies in a deal worth about 1.86 trillion rupiah ($120 million), a deputy minister said on Sunday.
Both SRF and INA will invest in listed PT Kimia Farma Tbk and its PT Kimia Farma Apotek unit, Indonesia's deputy minister for state-owned enterprises, Pahala Mansury, told a news conference in Bali on the sidelines of a G20 summit.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
